MATES SHARON (Chairman, President & CEO) received a stock award from INTRA-CELLULAR THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2025ACC: 0000950170-25-013765
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
+136.83K
Net shares
Net buyer
$1.93M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
152.06K acquired · 15.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30.85K
Price / share
—
Trade value
—
% of position
2.9%
1/31/2025
1.07M→1.10M
Common Stock
Direct
Shares
−15.23K
Price / share
$127.00
Trade value
$1.93M
% of position
1.4%
1/31/2025
1.10M→1.09M
Total
Net shares
+15.61K
Net value
-$1.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | A · Award | +30.85K | — | — | 2.9% | 1.07M | 1.10M |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −15.23K | $127.00 | $1.93M | 1.4% | 1.10M | 1.09M |
| Total | +15.61K | -$1.93M | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
121.21K shares
Shares
+121.21K
Strike price
Held after
121.21K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock121.21K shares | 2/3/2025 | A · Award | +121.21K | — | 121.21K |